Related Experiment Video
Updated: Sep 23, 2025

Inducible and Reversible Dominant-negative DN Protein Inhibition
Published on: January 7, 2019
Targeting HMGA protein inhibits retinoblastoma cell proliferation
Akilandeswari Balachandran1, Ajit Zambre2, Jagjot Singh Kainth2,3
1Department of Nanobiotechnology, Vision Research Foundation, Kamalnayan Bajaj Institute for Research in Vision and Ophthalmology Chennai India drkk@snmail.org drkrishnakumar_2000@yahoo.com.
Abstract:
We describe a novel synthetic strategy for conjugating HMGA2 siRNA and the HMGA aptamer to the nucleolin aptamer and nucleolin antibody, respectively. Our studies demonstrate that these conjugates inhibit cell proliferation in retinoblastoma cells.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Inhibition of Cdk Activity
Negative Regulator Molecules
Mitogens and the Cell Cycle
Abnormal Proliferation

